Stay updated with breaking news from Psychiatric Genetics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- The Global PTSD Genetics initiative founded in 2015 by Cohen Veterans Bioscience, the Stanley Center for Psychiatric Research at Broad...
Researcher who established the value of genetics for understanding psychiatric conditions
ISLAMABAD OCT: A new study published in a special edition of Science highlights the connections between particular cell types and various prevalent neuropsychiatric conditions.In the human brain...
<p>A special kind of genetic test that helps determine the best antidepressant for patients with moderate-to-severe depression could generate substantive health system savings and greatly improve patient outcomes, according to new research from the University of British Columbia. The study, published today in <a href="https://www.cmaj.ca/lookup/doi/10.1503/cmaj.221785"><em>CMAJ</em></a>, shows that in B.C. alone, implementing pharmacogenomic testing could save the provincial public health system an estimated $956 million over 20 years.</p>
It often takes months of experimentation to find an effective psychotropic drug. Up to half of patients with major depressive disorder do not respond to the first antidepressant prescribed. Kalamazoo's Genemarkers is among those offering a promising